MSP008-22

N/A

Report date: 2022/08/04 15:09:32
NME

Base Information

Drug NameMSP008-22
Drug Alias NameMSP008-22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGodavari Biorefineries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGodavari Biorefineries Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A